4//SEC Filing
Lewicki John A. 4
Accession 0000950170-24-007936
CIK 0001719714other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:15 PM ET
Size
5.7 KB
Accession
0000950170-24-007936
Insider Transaction Report
Form 4
Lewicki John A.
Chief Scientific Officer
Transactions
- Award
Share Options (Right to buy)
2024-01-25+137,000→ 137,000 totalExercise: $3.36Exp: 2034-01-25→ American Depository Shares (137,000 underlying)
Footnotes (2)
- [F1]25% of the shares underlying this share option will vest and become exercisable on January 25, 2025, with the remainder vesting in equal monthly installments for the three years thereafter.
- [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
Documents
Issuer
Mereo BioPharma Group plc
CIK 0001719714
Entity typeother
Related Parties
1- filerCIK 0001553352
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:15 PM ET
- Size
- 5.7 KB